Chemomab Therapeutics Ltd.
CMMB
$2.49
-$0.04-1.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.38% | 52.26% | -19.84% | -18.70% | -18.02% |
| Total Receivables | -40.09% | -32.87% | -26.10% | 4.72% | 116.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.33% | 1.35% | -1.33% | -3.90% | 0.00% |
| Total Current Assets | -19.36% | 47.84% | -20.09% | -17.98% | -19.07% |
|
|
|||||
| Total Current Assets | -19.36% | 47.84% | -20.09% | -17.98% | -19.07% |
| Net Property, Plant & Equipment | -6.59% | -6.48% | -5.95% | -8.62% | -8.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.05% | -9.32% | -8.53% | -6.38% | -5.87% |
| Total Assets | -18.82% | 43.68% | -19.24% | -17.60% | -18.69% |
|
|
|||||
| Total Accounts Payable | 72.54% | -65.32% | 111.20% | 5.86% | 31.34% |
| Total Accrued Expenses | -36.72% | 24.79% | -17.95% | -6.32% | -5.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.68% | 2.75% | -0.91% | -6.09% | -6.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -26.01% | 0.95% | -2.05% | -2.46% | 3.67% |
|
|
|||||
| Total Current Liabilities | -26.01% | 0.95% | -2.05% | -2.46% | 3.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.13% | -8.37% | -10.36% | -46.77% | -31.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.16% | 0.44% | -2.54% | -2.85% | 3.20% |
|
|
|||||
| Common Stock & APIC | 0.16% | 9.25% | 0.27% | 1.97% | 0.48% |
| Retained Earnings | -2.97% | -3.62% | -3.92% | -10.98% | -13.72% |
| Treasury Stock & Other | -- | -- | -- | 0.00% | 0.00% |
| Total Common Equity | -17.04% | 63.43% | -25.10% | -21.33% | -22.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.04% | 63.43% | -25.10% | -21.33% | -22.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.04% | 63.43% | -25.10% | -21.33% | -22.83% |
|
|
|||||